Activity Overview

This educational activity is an archive of the live conference held on April 11, 2026.

Target Audience

This educational activity is directed toward medical oncologists, surgical oncologists, radiation oncologists, gastroenterologists, and hepatologists who are interested in the treatment of GI cancers. Nurse practitioners, physician assistants, nurses, pathologists, pharmacists, and other health care professionals involved in the treatment and management of patients with GI cancers are invited to attend.

Learning Objectives

Assess the clinical utility of novel molecular and genomic strategies for personalizing treatment decisions in patients with gastrointestinal (GI) cancers
Evaluate the clinical impact of recent findings from landmark trials of emerging treatment strategies for the management of GI cancers

Module 1: Multidisciplinary Approaches in Localized GI Cancers

GET STARTED WITH THIS PROGRAM:

Create Account Already Registered? Login Here

Accreditation/Credit Designation

Physicians’ Education Resource^®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource^®, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource^®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 1.0 Contact Hour.

Acknowledgment of Commercial Support

This activity is supported by an educational grants from Daiichi Sankyo, Inc; Exact Sciences Corporation; Exelixis; and Partner Therapeutics.

Module 1: Multidisciplinary Approaches in Localized GI Cancers

GET STARTED WITH THIS PROGRAM:

Related Content